Sign in
bf/NASDAQ:KTTA_icon.jpeg

NASDAQ:KTTA

Pasithea Therapeutics Corp.

  • Stock

USD

Last Close

4.56

26/07 20:00

Market Cap

5.45M

Beta: -

Volume Today

2.75K

Avg: 58.36K

PE Ratio

−0.56

PFCF: −0.43

OverviewFinancialsFilingspeopleOwnershipAPIChartData

  • locale

    usUnited States

  • market

    STOCKS

  • industry

    Biotechnology

  • website

    www.pasithea.com

  • ipo date

    Sep 15, 2021

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Bea...Show More

Excel Tearsheet

peer of

Earnings

Earnings Release in 15 days

Earnings per Share (Estimate*)

-10-8-6-4-22020-09-302021-11-182022-05-162022-12-312023-11-132024-03-30

Revenue (Estimate*)

50K100K150K200K250K2020-09-302021-11-182022-05-162022-12-312023-11-132024-03-30

*Estimate based on analyst consensus